ArticleFood chemistry: X2025
Characterization of cold plasma-induced covalent epigallocatechin gallate conjugates of β-lactoglobulin: a comparison with free-radical and alkaline treatments.
Article in Food chemistry: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Modulation of structure, functionality, allergenicity andFood chemistry: X · 2026Article
- Research Progress on Protein-Polyphenol Interaction Mechanisms and Structure-Activity Relationship Modified by Physical Fields.Foods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The characteristics of cold plasma (CP)-induced β-lactoglobulin-epigallocatechin gallate (β-LG-EGCG) covalent conjugates were investigated in comparison with the conventional free -radical (FR) and alkaline treatment (AT) methods. Results indicated CP achieved a high EGCG grafting degree (116.73 ± 0.82 μmol/g, equivalent to 38.91 ± 0.27 % of grafting) after 45 s treatment, comparable to AT (131.79 ± 1.75 μmol/g, equivalent to 43.93 ± 0.58 % of grafting) and far exceeding FR (18.29 ± 0.67 μmol/g, equivalent to 6.10 ± 0.22 % of grafting). In addition, CP conjugates exhibited 27.51 % less browning than AT counterparts. Different from AT and FR, CP uniquely expanded EGCG-binding sites to include hydroxyl- and cyclic alkyl-containing residues. Multiple structural analyses revealed covalent grafting with EGCG induced conformational unfolding of β-LG and exposed buried hydrophobic groups. The CP-induced β-LG-EGCG conjugates yielded improvements comparable to AT in emulsifying and antioxidant properties. Moreover, CP-induced conjugates exhibited superior digestibility and lower antigenicity during gastrointestinal digestion. These findings demonstrated CP is a robust means of promoting covalent grafting between proteins and polyphenols, with high efficiency and enhanced functionality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.